Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 15, 04 December 2023
Open
Access | Article
Comparative study on treatment strategies for insomnia
* Author to whom correspondence should be addressed.
Abstract
Insomnia is a common sleep disorder that affects the typical quality of life of people. Different treatment strategies are required for insomnia caused by specific factors, such as environment and genetics. Currently, the two main categories of insomnia treatments are cognitive behavioral therapy for insomnia (CBT-I) and pharmacotherapy. However, each treatment has distinctive limitations. CBT-I lacks accessibility and certified facilitators, while pharmacotherapy is more prone to result in negative side effects, addiction, and physiological tolerance. To get over these limitations, it is necessary to come up with new alternative therapies to deal with insomnia effectively. This review is intended to summarize the different causes of insomnia and the latest existing treatments for insomnia. Based on previous studies, this study provides new ideas for future insomnia treatments.
Keywords
Insomnia, Treatments, Cognitive Behavioral Therapy For Insomnia (CBT-I), Pharmacotherapy
References
1. Thorpy MJ. Classification of sleep disorders. Neurotherapeutics 2012;9: 687-91.
2. Dopheide JA. Insomnia overview: epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy. Am J Manag Care 2020;26(4 Suppl): S76e84. https://doi.org/10.37765/ajmc.2020.42769.
3. Paul S, Vidusha K, Thilagar S, Lakshmanan DK, Ravichandran G, Arunachalam A. Advancement in the contemporary clinical diagnosis and treatment strategies of insomnia disorder. Sleep Med. 2022;91:124-140. doi:10.1016/j.sleep.2022.02.018
4. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guidelines for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4(5): 487e504.
5. Chigome AK, Nhira S, Meyer JC. An overview of insomnia and its management. S Afr Pharmaceut J 2018;85(2):32-8.
6. Journey, J. D., et al. (2022). Theophylline toxicity. StatPearls.
7. Özdağ, V., Koyuncu, O., Özdemir, Y. E., & Tanir, Y. (2022). Methylphenidate-Induced Menorrhagia in Twin Girls. Iranian journal of psychiatry, 17(4), 476–479. https://doi.org/10.18502/ijps.v17i4.10698
8. Banno K, Kryger MH. Comorbid insomnia. Sleep Medicine Clinics 2006;1(3): 367-74.
9. Mendes MS, dos Santos JM. Insomnia as an expression of obstructive sleep apnea syndrome – the effect of treatment with nocturnal ventilatory support. Rev Port Pneumol 21: 203–208, 2015.doi:10.1016/j.rppnen.2014.11.002.
10. Levenson JC, Kay DB, Buysse DJ. The pathophysiology of insomnia. Chest. 2015;147(4):1179–1192. doi:10.1378/chest.141617
11. Perlis ML, Gehrman P. Types of insomnia. In: Kushida Clete A, editor. Encyclopedia of sleep. Academic Press; 2013. p. 199e202. https://doi.org/ 10.1016/B978-0-12-378610-4.00175-3.
12. Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 changes on the national survey on drug use and health. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2016 Jun. Table 3.36, DSM-IV to DSM-5 Insomnia Disorder Comparison. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK519704/table/ch3.t36/.
13. Chigome AK, Nhira S, Meyer JC. An overview of insomnia and its management. S Afr Pharmaceut J 2018;85(2):32-8.
14. Morin, C. M., Drake, C. L., Harvey, A. G., Krystal, A. D., Manber, R., Riemann, D., & Spiegelhalder, K. (2015). Insomnia disorder. Nature reviews. Disease primers, 1, 15026. https://doi.org/10.1038/nrdp.2015.26
15. Hertenstein E, Spiegelhalder K, Johann A, Riemann DD. Pr€ avention und Psychotherapie der Insomnie. 1st ed. Stuttgart: Kohlhammer Verlag; 2015.
16. Benz F, Knoop T, Ballesio A, Bacaro V, Johann AF, Rücker G, et al. The efficacy of cognitive and behavior therapies for insomnia on daytime symptoms: a systematic review and network meta-analysis. Clin Psychol Rev 2020;80: 101873. https://doi.org/10.1016/j.cpr.2020.101873.
17. Wu JQ, Appleman ER, Salazar RD, Ong JC. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern Med 2015;175:1461e72. https://doi.org/10.1001/jamainte rnmed.2015.3006.
18. Koffel E, Bramoweth AD, Ulmer CS. Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review. J Gen Intern Med. 2018;33(6):955–962. doi:10.1007/s11606-018-4390-1
19. Pillai V, Roth T, Drake CL. The nature of stable insomnia phenotypes. Sleep. 2015;38(1):127–138. doi:10.5665/sleep.4338
20. Nowakowski S, Meers JM. Cognitive behavioral therapy for insomnia and women’s health: sex as a biological variable. Sleep Med Clin. 2019;14(2):185–197. doi:10.1016/j. jsmc.2019.01.002
21. de Zambotti M, Goldstone A, Colrain IM, Baker FC. Insomnia disorder in adolescence: Diagnosis, impact, and treatment. Sleep Med Rev. 2018 Jun;39:12-24. doi: 10.1016/j.smrv.2017.06.009. Epub 2017 Jul 1. PMID: 28974427; PMCID: PMC5931364.
22. de Bruin EJ, Bögels SM, Oort FJ, Meijer AM. Efficacy of cognitive behavioral therapy for insomnia in adolescents: a randomized controlled trial with internet therapy, group therapy, and a waiting list condition. Sleep. 2015; 38(12):1913–26. [PubMed: 26158889]
23. Lancee J, van Straten A, Morina N, Kaldo V, Kamphuis JH. Guided online or face-to-face cognitive behavioral treatment for insomnia: a randomized wait-list controlled trial. Sleep. 2016;39 (1):183–191. doi:10.5665/sleep.5344
24. Soh HL, Ho RC, Ho CS, Tam WW. Efficacy of digital cognitive behavioral therapy for insomnia: a meta-analysis of randomized controlled trials. Sleep Med. 2020;75:315–325. doi:10.1016/j. sleep.2020.08.020
25. Katzung, B. G. Basic and Clinical Pharmacology (McGraw-Hill Medical, 2009).
26. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307–349. doi:10.5664/ jcsm.6470
27. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–133. doi:10.7326/ M15-2175
28. Clay, E., Falissard, B., Moore, N. & T Rumi, M. Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries. Eur. J. Clin. Pharmacol. 69, 1–10 (2013).
29. Matheson E, Hainer BL. Insomnia: Pharmacologic Therapy. Am Fam Physician. 2017 Jul 1;96(1):29-35. PMID: 28671376.
30. Fick DM, Semla TP, Steinman M, et al. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.15767
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-193-3
- ISBN (Online)
- 978-1-83558-194-0
- Published Date
- 04 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/15/20240437
- Copyright
- 04 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited